Finally, the recently reported ligands, FAM150A and FAM150B activate not only the wild type ALK receptor, but also super-activate constitutive active ALK neuroblastoma variants, offering additional options for the inhibition of ALK activity in NB [27]. The gene discussed is ALKAL1; the disease is neuroblastoma.